Back
Rhythm Pharmaceuticals Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
100
RYTM
Rhythm Pharmaceuticals
Last Price:
67.31
Seasonality Move:
9.98%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
Rhythm Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.18 | Buy |
| 20-day SMA: | 52.43 | Buy |
| 50-day SMA: | 50.91 | Buy |
| 200-day SMA: | 45.07 | Buy |
| 8-day EMA: | 58.59 | Buy |
| 20-day EMA: | 54.14 | Buy |
| 50-day EMA: | 51.2 | Buy |
| 200-day EMA: | 44.61 | Buy |
Rhythm Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.14 | Buy |
| Relative Strength Index (14 RSI): | 81.29 | Buy |
| Chaikin Money Flow: | 966983 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.36 - 56.78) | Buy |
| Bollinger Bands (100): | (43.87 - 52.87) | Buy |
Rhythm Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rhythm Pharmaceuticals Stock
Is Rhythm Pharmaceuticals Stock a Buy?
- Rhythm Pharmaceuticals share price is 67.33 while RYTM 8-day simple moving average is 56.18, which is a Buy signal.
- The stock price of RYTM is 67.33 while Rhythm Pharmaceuticals 20-day SMA is 52.43, which makes it a Buy.
- Rhythm Pharmaceuticals 50-day simple moving average is 50.91 while RYTM share price is 67.33, making it a Buy technically.
- RYTM stock price is 67.33 and Rhythm Pharmaceuticals 200-day simple moving average is 45.07, creating a Buy signal.
RYTM Technical Analysis vs Fundamental Analysis
Buy
100
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy or a Sell?
-
Rhythm Pharmaceuticals stock is rated a Buy
The current Rhythm Pharmaceuticals [RYTM] share price is $67.33. The Score for RYTM is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
Rhythm Pharmaceuticals Stock Info
Market Cap:
4.14B
Price in USD:
67.33
Share Volume:
1.1M
Rhythm Pharmaceuticals 52-Week Range
52-Week High:
67.61
52-Week Low:
26.55
Buy
100
Rhythm Pharmaceuticals (RYTM)
is a Buy
Rhythm Pharmaceuticals Share Price Forecast
-
What is the Rhythm Pharmaceuticals stock price today?
The Rhythm Pharmaceuticals stock price is 67.33 USD today. -
Will RYTM stock go up or go down?
Rhythm Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Rhythm Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rhythm Pharmaceuticals is not overvalued.
Is Rhythm Pharmaceuticals Stock a Buy?
- Rhythm Pharmaceuticals share price is 67.33 while RYTM 8-day exponential moving average is 58.59, which is a Buy signal.
- The stock price of RYTM is 67.33 while Rhythm Pharmaceuticals 20-day EMA is 54.14, which makes it a Buy.
- Rhythm Pharmaceuticals 50-day exponential moving average is 51.20 while RYTM share price is 67.33, making it a Buy technically.
- RYTM stock price is 67.33 and Rhythm Pharmaceuticals 200-day simple moving average is 44.61, creating a Buy signal.
Fundamental Analysis of Rhythm Pharmaceuticals
Is Rhythm Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.
Technical Analysis of Rhythm Pharmaceuticals
Should I short Rhythm Pharmaceuticals stock?
- RYTM Moving Average Covergence Divergence (MACD) indicator is 3.14, suggesting Rhythm Pharmaceuticals is a Buy
- Rhythm Pharmaceuticals Relative Strength Index (RSI) is 81.29, which suggest Rhythm Pharmaceuticals is overbought
- The Bollinger Bands (25) for Rhythm Pharmaceuticals is (46.36 - 56.78), which suggest Rhythm Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Rhythm Pharmaceuticals is (43.87 - 52.87), which suggest Rhythm Pharmaceuticals is a Buy
* Rhythm Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.